| Discussion Topic |
Replies (estimated) |
Archive Link
|
| Citation needed |
5 |
Talk:Fluvoxamine/Archive 1#Citation needed
|
| Cleanup, references and WP:NPOV |
1 |
Talk:Fluvoxamine/Archive 1#Cleanup, references and WP:NPOV
|
| Historical relevance |
1 |
Talk:Fluvoxamine/Archive 1#Historical relevance
|
| effect of luvox on the brain |
1 |
Talk:Fluvoxamine/Archive 1#effect of luvox on the brain
|
| SSRI |
1 |
Talk:Fluvoxamine/Archive 1#SSRI
|
| Manufacturers |
1 |
Talk:Fluvoxamine/Archive 1#Manufacturers
|
| Ciprofloxacine |
1 |
Talk:Fluvoxamine/Archive 1#Ciprofloxacine
|
| Paedophilia |
1 |
Talk:Fluvoxamine/Archive 1#Paedophilia
|
| Longest half-life? |
1 |
Talk:Fluvoxamine/Archive 1#Longest half-life?
|
| Bioavailability inconsistency |
1 |
Talk:Fluvoxamine/Archive 1#Bioavailability inconsistency
|
| Chemical name |
1 |
Talk:Fluvoxamine/Archive 1#Chemical name
|
| Fluvoxamine connected to circadian rhythm sleep disorders, as distinguished from other SSRIs. |
3 |
Talk:Fluvoxamine/Archive 1#Fluvoxamine connected to circadian rhythm sleep disorders, as distinguished from other SSRIs.
|
| Countries |
2 |
Talk:Fluvoxamine/Archive 1#Countries
|
| Largest manufacturer |
1 |
Talk:Fluvoxamine/Archive 1#Largest manufacturer
|
| Fluoride content and bioavailability of Fluoride from Fluvoxamine, compared to fluoride from drinking water and food? |
1 |
Talk:Fluvoxamine/Archive 1#Fluoride content and bioavailability of Fluoride from Fluvoxamine, compared to fluoride from drinking water and food?
|
| Information on use for treating COVID |
23 |
Talk:Fluvoxamine/Archive 1#Information on use for treating COVID
|
| Contradictory information on the strength of Fluvoxamine's inhibition of CYP2D6 |
2 |
Talk:Fluvoxamine/Archive 1#Contradictory information on the strength of Fluvoxamine's inhibition of CYP2D6
|
| Suggestions for Additions |
1 |
Talk:Fluvoxamine/Archive 1#Suggestions for Additions
|
| Dashes |
1 |
Talk:Fluvoxamine/Archive 1#Dashes
|
| Puff claim not in cite |
1 |
Talk:Fluvoxamine/Archive 1#Puff claim not in cite
|
| Unconsummated citations |
1 |
Talk:Fluvoxamine/Archive 1#Unconsummated citations
|
| Efficacy numbers against COVID-19 hospitalization: undue? |
6 |
Talk:Fluvoxamine/Archive 1#Efficacy numbers against COVID-19 hospitalization: undue?
|
| Additional Covid sources |
1 |
Talk:Fluvoxamine/Archive 1#Additional Covid sources
|
| Elimination half-life. 12-13 hours for single dose, 22 hours for repeated dosing |
1 |
Talk:Fluvoxamine#Elimination half-life. 12-13 hours for single dose, 22 hours for repeated dosing
|
| Sentence under society and culture |
4 |
Talk:Fluvoxamine#Sentence under society and culture
|
| Sourcing |
3 |
Talk:Fluvoxamine#Sourcing
|
| ACTIV-6 |
4 |
Talk:Fluvoxamine#ACTIV-6
|
